LONDON (Reuters) - GlaxoSmithKline and the non-profit biotech group Aeras are to assess an experimental tuberculosis vaccine in "proof of concept" tests in Africa and India, marking a step forward in the hunt for new ways to prevent the ...
Source: http://health.yahoo.net/news/s/nm/gsk-and-aeras-to-test-tb-vaccine-in-africa-india
example here as example as an example explained here
No comments:
Post a Comment
Note: only a member of this blog may post a comment.